CN118515685A - 软海绵素的合成 - Google Patents

软海绵素的合成 Download PDF

Info

Publication number
CN118515685A
CN118515685A CN202410481438.XA CN202410481438A CN118515685A CN 118515685 A CN118515685 A CN 118515685A CN 202410481438 A CN202410481438 A CN 202410481438A CN 118515685 A CN118515685 A CN 118515685A
Authority
CN
China
Prior art keywords
optionally substituted
formula
hydrogen
compound
salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202410481438.XA
Other languages
English (en)
Chinese (zh)
Inventor
Y·岸
Y·艾
N·叶
Q·王
K·矢幡
K·矶
S·R·奈尼
S·山下
J·李
大桥功
福山尚
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eisai R&D Management Co Ltd
Harvard University
Original Assignee
Eisai R&D Management Co Ltd
Harvard University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai R&D Management Co Ltd, Harvard University filed Critical Eisai R&D Management Co Ltd
Publication of CN118515685A publication Critical patent/CN118515685A/zh
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/22Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains four or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Carbon And Carbon Compounds (AREA)
  • Silicates, Zeolites, And Molecular Sieves (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Furan Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Catalysts (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
CN202410481438.XA 2017-07-06 2018-07-06 软海绵素的合成 Pending CN118515685A (zh)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US201762529333P 2017-07-06 2017-07-06
US201762529310P 2017-07-06 2017-07-06
US62/529,333 2017-07-06
US62/529,310 2017-07-06
CN201880058283.1A CN111433211B (zh) 2017-07-06 2018-07-06 软海绵素的合成
PCT/US2018/041005 WO2019010363A1 (en) 2017-07-06 2018-07-06 HALICHONDRINES SYNTHESIS

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CN201880058283.1A Division CN111433211B (zh) 2017-07-06 2018-07-06 软海绵素的合成

Publications (1)

Publication Number Publication Date
CN118515685A true CN118515685A (zh) 2024-08-20

Family

ID=63036376

Family Applications (2)

Application Number Title Priority Date Filing Date
CN202410481438.XA Pending CN118515685A (zh) 2017-07-06 2018-07-06 软海绵素的合成
CN201880058283.1A Active CN111433211B (zh) 2017-07-06 2018-07-06 软海绵素的合成

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN201880058283.1A Active CN111433211B (zh) 2017-07-06 2018-07-06 软海绵素的合成

Country Status (14)

Country Link
US (2) US11548898B2 (https=)
EP (2) EP3649135B1 (https=)
JP (2) JP7370313B2 (https=)
KR (2) KR102438417B1 (https=)
CN (2) CN118515685A (https=)
AU (2) AU2018297305B2 (https=)
BR (1) BR112020000141A2 (https=)
CA (2) CA3211559A1 (https=)
ES (1) ES2940688T3 (https=)
HU (1) HUE061306T2 (https=)
IL (3) IL295588B2 (https=)
MX (1) MX2020000142A (https=)
SG (1) SG11201912342QA (https=)
WO (1) WO2019010363A1 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10556910B2 (en) 2014-06-30 2020-02-11 President And Fellows Of Harvard College Synthesis of halichondrin analogs and uses thereof
US10344038B2 (en) 2015-04-30 2019-07-09 President And Fellows Of Harvard College Chromium-mediated coupling and application to the synthesis of halichondrins
JP6978758B2 (ja) 2016-11-11 2021-12-08 プレジデント アンド フェローズ オブ ハーバード カレッジ パラジウム媒介ケトール化
ES2931533T3 (es) 2017-04-05 2022-12-30 Harvard College Compuesto macrocíclico y usos del mismo
US9938288B1 (en) 2017-04-05 2018-04-10 President And Fellows Of Harvard College Macrocyclic compound and uses thereof
HUE061306T2 (hu) 2017-07-06 2023-06-28 Harvard College Halikondrinok szintézise
US11498892B2 (en) 2017-07-06 2022-11-15 President And Fellows Of Harvard College Fe/Cu-mediated ketone synthesis
CN111566113B (zh) * 2017-11-15 2024-01-09 哈佛大学的校长及成员们 大环化合物及其用途
CN111484393A (zh) * 2019-01-28 2020-08-04 上海茂晟康慧科技有限公司 一种顺,顺-3,5-二甲基-1-环己醇的制备方法
CN117820275A (zh) * 2023-12-29 2024-04-05 上海科技大学 一种列净类药物及其中间体的催化合成方法

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61191687A (ja) 1985-02-20 1986-08-26 Fujisawa Pharmaceut Co Ltd ハリコンドリンb
US5338865A (en) 1992-03-12 1994-08-16 President And Fellows Of Harvard College Synthesis of halichondrin B and norhalichondrin B
US5436238A (en) 1992-03-12 1995-07-25 President And Fellows Of Harvard College Halichondrins and related compounds
GB9206244D0 (en) 1992-03-23 1992-05-06 Pharma Mar Sa Cytotoxic compound from a marine sponge
US5426194A (en) 1993-01-19 1995-06-20 Arizona Board Of Regents, A Body Corporate Acting On Behalf Of Arizona State University Isolation and structure of Halistatin 1
US5352804A (en) 1993-01-19 1994-10-04 Arizona Board Of Regents, A Body Corporate, Acting On Behalf Of Arizona State University Isolation and structure of Halistatin 2
JP2818381B2 (ja) 1994-01-18 1998-10-30 帝人株式会社 7−チアプロスタグランジン類およびその製造法
US8097648B2 (en) 1998-06-17 2012-01-17 Eisai R&D Management Co., Ltd. Methods and compositions for use in treating cancer
US6653341B1 (en) 1998-06-17 2003-11-25 Eisai Co., Ltd. Methods and compositions for use in treating cancer
US6214865B1 (en) 1998-06-17 2001-04-10 Eisai Co., Ltd. Macrocyclic analogs and methods of their use and preparation
JP2001305734A (ja) 2000-04-20 2001-11-02 Fuji Photo Film Co Ltd 光重合性組成物
JP2003261447A (ja) 2002-03-07 2003-09-16 Kyosei Seiyaku Kk 抗腫瘍剤
EP2522663B1 (en) 2004-06-03 2015-04-01 Eisai R&D Management Co., Ltd. Intermediates for the preparation of halichondrin B
EP1831697A4 (en) 2004-12-09 2011-01-26 Eisai R&D Man Co Ltd SEARCH FOR TUBULINISOTYPES IN CANCER THERAPY USING HALICHONDRIN B ANALOG
JP2009184924A (ja) 2006-05-31 2009-08-20 Eisai R & D Management Co Ltd 生物学的試薬用化合物
MY153742A (en) 2007-03-07 2015-03-13 Interdigital Tech Corp Method and apparatus for generating and processing a mac-ehs protocol data unit
US20100254996A1 (en) 2007-06-18 2010-10-07 Medimmune, Llc Synergistic treatment of cells that express epha2 and erbb2
RU2489437C2 (ru) * 2007-10-03 2013-08-10 Эйсай Ар Энд Ди Менеджмент Ко., Лтд. Промежуточные соединения и способы синтеза аналогов галихондрина в
RU2010118063A (ru) 2007-11-16 2011-12-27 ЭЙСАЙ Ар энд Ди МЕНЕДЖМЕНТ КО., ЛТД. (JP) Новое промежуточное соединение для синтеза аналога галихондрина в и новая реакция десульфонилирования, применяемая для получения промежуточного соединения
CN105801599A (zh) 2008-04-04 2016-07-27 卫材R&D管理有限公司 软海绵素b类似物
WO2011094339A1 (en) 2010-01-26 2011-08-04 Eisai R&D Management Co., Ltd. Furo [3, 2 -b] pyrane derivatives useful in the synthesis of halichondrin b analogs
WO2012096926A2 (en) 2011-01-10 2012-07-19 President And Fellows Of Harvard College Method for delivering agents into cells using bacterial toxins
WO2012147900A1 (en) 2011-04-28 2012-11-01 Eisai R&D Management Co., Ltd. Microreactor process for halichondrin b analog synthesis
CN104024237B (zh) 2011-12-16 2016-02-24 阿方拉研究股份有限公司 用于制备3-((2s,5s)-4-亚甲基-5-(3-氧代丙基)四氢呋喃-2-基)丙醇衍生物的方法及其有用的中间体
CN104080793B (zh) 2011-12-29 2017-09-19 阿方拉研究股份有限公司 2‑((2s,3s,4r,5r)‑5‑((s)‑3‑氨基‑2‑羟基丙‑1‑基)‑4‑甲氧基‑3‑(苯磺酰甲基)四氢呋喃‑2‑基)乙醛衍生物以及它们的制备方法
WO2013142999A1 (en) 2012-03-30 2013-10-03 Alphora Research Inc. Synthetic process for preparation of macrocyclic c1-keto analogs of halichondrin b and intermediates useful therein
AR096238A1 (es) 2013-05-15 2015-12-16 Alphora Res Inc Proceso para preparar derivados de 3-((2s,5s)-4-metilen-5-(3-oxopropil)tetrahidrofuran-2-il)propanol e intermediarios útiles para el mismo
CA2916537C (en) 2013-07-03 2021-07-27 Alphora Research Inc. Synthetic process for preparation of macrocyclic c1-keto analogs of halichondrin b and intermediates useful therein including intermediates containing -so2-(p-tolyl) groups
EP3689881B1 (en) 2013-11-04 2022-01-12 Eisai R&D Management Co., Ltd. Macrocyclization reactions and intermediates useful in the synthesis of analogs of halichondrin b
MX384292B (es) 2013-12-06 2025-03-14 Eisai R&D Man Co Ltd Metodos utiles en la sintesis de analogos de halicondrina b.
US10556910B2 (en) 2014-06-30 2020-02-11 President And Fellows Of Harvard College Synthesis of halichondrin analogs and uses thereof
WO2016038624A1 (en) 2014-09-09 2016-03-17 Cipla Limited "process for the preparation of macrocyclic ketone analogs of halichondrin b or pharmaceutically acceptable salts and intermediates thereof"
US10344038B2 (en) 2015-04-30 2019-07-09 President And Fellows Of Harvard College Chromium-mediated coupling and application to the synthesis of halichondrins
KR102743950B1 (ko) 2015-05-07 2024-12-18 에자이 알앤드디 매니지먼트 가부시키가이샤 할리콘드린 마크롤라이드의 합성에 유용한 마크로고리화 반응 및 중간체 및 기타 단편
EP3423105B1 (en) 2016-03-02 2021-05-05 Eisai R&D Management Co., Ltd. Eribulin-based antibody-drug conjugates and methods of use
JP6978758B2 (ja) 2016-11-11 2021-12-08 プレジデント アンド フェローズ オブ ハーバード カレッジ パラジウム媒介ケトール化
JP2020508315A (ja) 2017-02-20 2020-03-19 ポリフォー・アクチェンゲゼルシャフトPolyphor Ag がんを治療するための薬剤組合せ
US9938288B1 (en) 2017-04-05 2018-04-10 President And Fellows Of Harvard College Macrocyclic compound and uses thereof
ES2931533T3 (es) 2017-04-05 2022-12-30 Harvard College Compuesto macrocíclico y usos del mismo
WO2019009956A1 (en) 2017-07-06 2019-01-10 President And Fellows Of Harvard College SUMMARY OF MEDIUM MEDIATED KETONE
US11498892B2 (en) 2017-07-06 2022-11-15 President And Fellows Of Harvard College Fe/Cu-mediated ketone synthesis
HUE061306T2 (hu) 2017-07-06 2023-06-28 Harvard College Halikondrinok szintézise
CN111566113B (zh) 2017-11-15 2024-01-09 哈佛大学的校长及成员们 大环化合物及其用途

Also Published As

Publication number Publication date
JP7370313B2 (ja) 2023-10-27
KR20220124279A (ko) 2022-09-13
AU2018297305A1 (en) 2020-01-16
KR102438417B1 (ko) 2022-09-01
IL307273B2 (en) 2025-03-01
EP4169924A3 (en) 2023-07-05
CN111433211A (zh) 2020-07-17
CA3211559A1 (en) 2019-01-10
US11548898B2 (en) 2023-01-10
ES2940688T3 (es) 2023-05-10
AU2023203013A1 (en) 2023-06-01
HUE061306T2 (hu) 2023-06-28
KR20200042464A (ko) 2020-04-23
IL271660A (en) 2020-02-27
EP4169924A2 (en) 2023-04-26
EP3649135A1 (en) 2020-05-13
WO2019010363A8 (en) 2019-06-06
IL307273A (en) 2023-11-01
JP7764432B2 (ja) 2025-11-05
CA3069160C (en) 2023-10-17
AU2023203013B2 (en) 2025-06-05
IL307273B1 (en) 2024-11-01
IL295588A (en) 2022-10-01
BR112020000141A2 (pt) 2020-07-14
CA3069160A1 (en) 2019-01-10
EP3649135B1 (en) 2022-12-28
IL295588B2 (en) 2024-03-01
CN111433211B (zh) 2024-05-07
JP2020536046A (ja) 2020-12-10
WO2019010363A1 (en) 2019-01-10
JP2023166381A (ja) 2023-11-21
MX2020000142A (es) 2020-07-22
AU2018297305B2 (en) 2023-02-16
RU2020104842A (ru) 2021-08-06
US20230128195A1 (en) 2023-04-27
SG11201912342QA (en) 2020-01-30
IL271660B (en) 2022-09-01
US20210230177A1 (en) 2021-07-29
IL295588B1 (en) 2023-11-01

Similar Documents

Publication Publication Date Title
JP7764432B2 (ja) ハリコンドリンの合成
US11220513B2 (en) Chromium-mediated coupling and application to the synthesis of halichondrins
EP2550285B1 (en) Trioxacarcins and uses thereof
WO2016003975A1 (en) Synthesis of halichondrin analogs and uses thereof
EP3664799A1 (en) Lincosamide antibiotics and uses thereof
RU2794176C2 (ru) Синтез галихондринов
Wong Synthetic Studies Towards the 13-Desmethyl Spirolide C Bis-Spiroketal Fragment
Schönbauer Towards the total synthesis of Elisabethine A
WO2026025019A1 (en) Synthesis of macrobicyclic thiolincosamines
Steinacher Towards the total synthesis of providencin
Veliz Part I. Studies towards the total synthesis of zoanthamine alkaloids. Part II. Total synthesis of (-)-lankacyclinol
Roushanbakhti Synthesis of the EFG-ring system of pectenotoxin-4
Clark Synthetic studies towards discodermolide and a total synthesis of didehydrodiscodermolide
Martin Progress toward the total synthesis of the marine natural product amphidinol 3
Leger Hydroamination and C–C Activation Methods for the Expedient Synthesis of Lycopodium Alkaloids and Phomactin Natural Products
Truong Samarium iodide directed reductions of β-amino ketones and the total synthesis of bryostatin analogs
Oyelaran Toward a syntheses of the ingenol core and cephalostatin 1
Underwood Synthesis and determination of the absolute configuration of Armatol A through a polyepoxide cyclization cascade: revision of the proposed structures of Armatols AF
Gordon Applications of a Concise and General Strategy for the Syntheses of Transtaganolide and Basiliolide Natural Products
Sciotti The total synthesis of (-)-clorothricolide

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination